(Q39175999)

English

Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation

scientific article published on June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation (English)

1 reference

Europe PubMed Central

9 September 2017

transmembrane protein

0 references

author name string

Daniela Meyer

1

1 reference

Europe PubMed Central

9 September 2017

Frank Sielaff

2

1 reference

Europe PubMed Central

9 September 2017

Maya Hammami

3

1 reference

Europe PubMed Central

9 September 2017

Eva Böttcher-Friebertshäuser

4

1 reference

Europe PubMed Central

9 September 2017

Wolfgang Garten

5

1 reference

Europe PubMed Central

9 September 2017

Torsten Steinmetzer

6

1 reference

Europe PubMed Central

9 September 2017

language of work or name

0 references

publication date

1 June 2013

1 reference

Europe PubMed Central

9 September 2017

Biochemical Journal

1 reference

Europe PubMed Central

9 September 2017

452

1 reference

Europe PubMed Central

9 September 2017

2

1 reference

Europe PubMed Central

9 September 2017

331-343

1 reference

Europe PubMed Central

9 September 2017

Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Type II transmembrane serine proteases in development and disease

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Phenotypic analysis of mice lacking the Tmprss2-encoded protease

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Host cell proteases controlling virus pathogenicity

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Aprotinin and similar protease inhibitors as drugs against influenza

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

The determination of enzyme inhibitor constants

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Identification of the first low-molecular-weight inhibitors of matriptase-2.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

The Determination of the Concentration of Hydrolytic Enzyme Solutions: α-Chymotrypsin, Trypsin, Papain, Elastase, Subtilisin, and Acetylcholinesterase1

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Determination of the operational molarity of solutions of bovine α-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

3-Amidinophenylalanine-based inhibitors of urokinase

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Ligand binding stepwise disrupts water network in thrombin: enthalpic and entropic changes reveal classical hydrophobic effect

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

A new strategy for the development of highly potent and selective plasmin inhibitors

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Protease-activated receptors and myocardial infarction

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

A new oral anticoagulant: the 50-year challenge

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinity.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Lessons learned from marketed and investigational prodrugs

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130101

21 January 2018

Identifiers

10.1042/BJ20130101

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39175999&oldid=1811881682"